GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Tilray Brands TLRY · USD

Health Care · US listing · 🇺🇸 United States

Compare

2.85

-2.40%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$821.3m

FY2016FY2025

Net income

−$2.19bn

FY2016FY2025

Free cash flow

−$127.5m

FY2016FY2025

Shareholders' equity

$1.51bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$821.3m$788.9m$627.1m$628.4m$513.1m$210.5m$167.0m$43.1m$20.5m$12.6m
Research and development$284,000$635,000$682,000$1.5m$830,000$4.4m$6.6m$4.3m$3.2m$1.1m
Operating income−$107.8m−$97.0m−$179.1m−$216.3m−$132.2m−$131.8m−$216.6m−$57.6m−$7.5m−$7.0m
Net income−$2.19bn−$245.0m−$1.45bn−$476.8m−$367.4m−$271.1m−$321.2m−$67.7m−$7.8m−$7.9m
Diluted earnings per share-24.56-3.29-23.50-9.90-13.63-21.50-31.97-8.15-0.85-0.85

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$2.07bn$4.22bn$4.31bn$5.45bn$6.03bn$945.9m$896.3m$656.7m$53.9m$33.1m
Cash and short-term investments$256.4m$260.5m$448.5m$415.9m$488.5m$189.7m$96.8m$517.6m$2.3m$7.5m
Total liabilities$562.9m$778.8m$991.6m$1.05bn$1.57bn$572.0m$611.1m$459.0m$58.8m$30.6m
Debt$302.7m$366.8m$579.8m$605.8m$916.6m$307.8m$444.4m$429.1m$51.2m$28.7m
Shareholders' equity$1.51bn$3.44bn$3.32bn$4.40bn$4.46bn$373.9m$285.3m$197.7m−$4.9m$2.5m
Shares outstanding89m74m62m48m27m13m10m8m9m9m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−$94.6m−$30.9m$7.9m−$177.3m−$44.7m−$129.4m−$258.1m−$46.2m−$6.4m−$3.3m
Capital spending−$32.9m−$29.2m−$20.8m−$34.1m−$38.9m−$44.6m−$78.6m−$54.5m−$11.4m−$1.0m
Free cash flow−$127.5m−$60.2m−$12.9m−$211.3m−$83.6m−$174.0m−$336.7m−$100.7m−$17.8m−$4.3m

Latest quarters

By quarter end

Nov 2025Aug 2025May 2025Feb 2025Nov 2024Aug 2024May 2024Feb 2024
Revenue$217.5m$209.5m$224.5m$185.8m$210.9m$200.0m$229.9m$188.3m
Operating income−$20.0m$4.1m−$12.7m−$31.4m−$34.2m−$29.6m−$11.7m−$27.4m
Net income−$44.9m−$322,000−$1.27bn−$789.4m−$85.3m−$39.2m−$31.7m−$92.7m
Diluted earnings per share-0.41-0.00-13.00-8.69-0.98-0.44-0.39-1.22
Total assets$2.10bn$2.08bn$2.07bn$3.40bn$4.19bn$4.26bn$4.22bn$4.21bn
Cash and short-term investments$291.6m$264.8m$256.4m$248.4m$252.2m$280.1m$260.5m$225.9m
Debt$277.2m$280.6m$286.4m$308.8m$334.4m$349.8m$349.9m$362.9m
Shareholders' equity$1.58bn$1.54bn$1.51bn$2.73bn$3.47bn$3.48bn$3.44bn$3.36bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue9.3%31.3%—
Operating income-20.7%-3.9%—
Net income66.1%51.8%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Price to earnings-0.4-4.0-1.0-2.7-5.2-1.9-2.7-43.5
Price to sales1.01.32.32.13.72.55.268.3

Share price return

Finished calendar years

20252024202320222021202020192018
Return6%-43%-31%-60%77%-52%-78%250%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 10-to-1 reverse split · 2 Dec 2025

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.